Cash Flow from Investing Activities: The total change in cash resulting from a company's investments.
Emergent Biosolutions Inc. (EBS) had Cash Flow from Investing Activities of $-50.10M for the most recently reported fiscal quarter, ending 2026-09-30.
| Income Statement Financials | |
$110.00M |
|
$-32.70M |
|
$80.80M |
|
$29.20M |
|
$147.30M |
|
$-37.30M |
|
$0.90M |
|
$-36.40M |
|
$-36.40M |
|
$-32.70M |
|
$-32.70M |
|
$-32.70M |
|
$-32.70M |
|
$-37.30M |
|
$-18.70M |
|
51.30M |
|
51.30M |
|
$-0.64 |
|
$-0.64 |
|
| Balance Sheet Financials | |
$558.20M |
|
$174.80M |
|
$437.00M |
|
$995.20M |
|
$122.00M |
|
$507.70M |
|
$560.00M |
|
$682.00M |
|
$313.20M |
|
$60.70M |
|
$313.20M |
|
51.30M |
|
| Cash Flow Statement Financials | |
$122.40M |
|
|
Cash Flow from Investing Activities |
$-50.10M |
$-104.50M |
|
$209.10M |
|
$176.90M |
|
$-32.20M |
|
$13.00M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
4.58 |
|
-- |
|
-- |
|
0.62 |
|
1.62 |
|
26.55% |
|
-33.91% |
|
-33.91% |
|
-- |
|
-33.09% |
|
-29.73% |
|
$120.20M |
|
-- |
|
-- |
|
-- |
|
0.11 |
|
0.29 |
|
1.42 |
|
63.41 |
|
-10.44% |
|
-53.87% |
|
-3.29% |
|
-3.98% |
|
$6.11 |
|
$2.34 |
|
$2.39 |
|